Main Conference Page Conference Registration
Wednesday, September 14, 2011
|
Applying New Materials to Enable Innovative Devices |
10:30 – 12:30 |
Part III: Applications for Specialty Materials: Opportunities and Challenges Ahead |
Hear applications-based presentations on:
New Materials for Medical Devices-Is it Possible?: Melissa Reynolds, Assistant Professor of Chemistry, Colorado State University
The development of a truly biocompatible synthetic material for medical device applications has been the focus of both academic and industrial researchers world-wide for decades. As the world''s population continues to live longer, the need for medical technologies that support and maintain the quality of life for people is growing exponentially. At the forefront of this need is the development of more effective as well as longer lasting medical materials for a range of applications. This presentation will focus on the progression of material design approaches from preventing biochemical processes towards integrative therapies. Attention will be placed on how past successes and failures in materials development can be used to inform our ability to create biointerfaces with improved biocompatibility.
•New materials •Biocompatibility •Biodegradable polymers •Interactive materials
Advances in PEEK Biomaterials for Implant Applications: Steven Kurtz, Ph.D., Corporate Vice President & Director, Exponent
Developed in the 1980s, Polyetheretherketone (PEEK) is a relatively new structural biomaterial that is gaining increased acceptance for use in orthopedic, trauma, spine, and dental implants. With over a decade of clinical experience, PEEK composites can be tailored with elastic moduli ranging from titanium alloy, at the high end, to cortical and cancellous bone, at the low end of the spectrum. Used initially in spinal cages due to its MRI-compatibility, recent PEEK implant development has been focused on isoelastic hip stems, thin orthopedic bearings, bioactive composites, and dental materials. This talk provides an overview of recent developments in the applications for PEEK biomaterials as well as and recent advances in metal and hydroxyapatite coatings, plasma treatment, porous PEEK, silver-PEEK composites for anti-infection, and bioactive PEEK composites. •Polyetheretherketone Real Life Considerations for the Development of Combination Products: Andrew Luk, Ph.D., Senior Director, New Technologies R&D, Cooper Vision
Drug-device combination covers a wide variety of possible product concepts. Understanding the fundamental mechanism of action of such combo concept is paramount to mapping out a successful development strategy towards proof-of-concept and subsequent commercialization. To ensure proper execution, project team must appreciate differences between drug and device development in order to proactively address any issues by seeking proper diverse input. This presentation will outline a unique technical perspective in analyzing drug-device combination concepts and discuss a number of real life challenges facing project team involved in this line of work.
• Analyze mechanism of action of combo products using sound drug delivery principles
|
Admission to the Conference is complimentary for employees of qualifying implantable device manufacturers.
For all others, a registration fee will apply. Your colleagues can register online at MEDeviceForum.com.
ABOUT THE CHAIR
Brian Buntz, Managing Editor, MD&DI
Brian Buntz is a Managing Editor at UBM Canon. He has been employed by UBM Canon for almost six years. He attended the University of Oklahoma where he also worked as a teaching assistant. He began his tenure at European Medical Device Technology. In 2011, he joined the editorial staff of MD+DI. Brian holds a bachelor's degree in physics and a master's degree in German.
ABOUT THE SPEAKERS
Melissa Reynolds, Assistant Professor of Chemistry, Colorado State University
Dr. Reynolds is currently a faculty member in the Department of Chemistry and holds a joint appointment in the School of Biomedical Engineering at Colorado State University. She received her Ph.D. in chemistry from the University of Michigan in Dr. Mark E. Meyerhoff's laboratory where she developed new methods for preparing nitric oxide releasing polymeric materials. Following graduate school she initiated a new biomaterials program aimed at developing new coatings for medical devices. During her tenure, she designed and implemented both synthesis and characterization programs, was awarded several million dollars in NIH funding, formed both industrial and academic partnerships, coordinated cross-organizational studies for new product development pipelines, and created a comprehensive IP portfolio through licensing and internal research. Her leadership led to the formation of a venture backed spin-off company. She has authored over 25 papers/presentations and has been given a Science Award from the National Institutes of Health in recognition of her work.
Steven Kurtz, Ph.D., Corporate Vice President & Director, Exponent
Dr. Steven M. Kurtz is a Corporate Vice President and Director of Exponent's Philadelphia, Pennsylvania office. Concurrently, he serves as a part-time Research Professor and director of the Implant Research Center at Drexel University's School of Biomedical Engineering, Science, and Health Systems. Dr. Kurtz's professional career has involved the evaluation of medical device technologies, from a combined analytical, experimental, and clinical perspective. His research activities have emphasized real-world clinical performance of medical devices, including orthopedic, spine, and cardiovascular implants, as assessed by human implant retrieval specimens and national health care databases; mechanical behavior of synthetic biomaterials; contact mechanics of artificial joints; and structural evaluation of bone-implant systems. Dr. Kurtz is active in many professional societies, including the American Academy of Orthopedic Surgeons, the Spine Arthroplasty Society, and the American Society for Testing and Materials. Dr. Kurtz has edited four books and written over 110 journal articles and 300 conference abstracts. He is the founding editor of two educational websites: the UHMWPE Lexicon (www.uhmwpe.org) and the Medical PEEK Lexicon (www.medicalpeek.org). He has recently completed the 2nd Edition of the UHMWPE Biomaterials Handbook.
Andrew Luk, Ph.D., Senior Director, New Technologies R&D, Cooper Vision
Andrew has been engaged in combination product work for over 10 years, with development experiences in both pharmaceutical products and medical devices. He is currently with CooperVision R&D as the Senior Director of New Technologies. Prior to joining CooperVision, Andrew was the Senior Director R&D at Conor Medsystem (acquired by Cordis/J&J in 2007) and Engineering Fellow/Product Development Manager with ALZA (acquired by J&J in 2001). Prior to these two companies, Andrew was with AstraZeneca as a team leader to develop global crop protection products. Andrew graduated with a Ph.D. in Chemical Engineering from University of Delaware and a B.S. in Chemical Engineering from New Jersey Institute of Technology.
Main Conference Page Conference Registration Contact Us